Assertion: atropine | /r/HasProperty | injection
Facets:
Source sentences:
text: There is limited information regarding Clinical Trial Experience of Atropine (Injection) in the drug label.
text: There is limited information regarding Drug Interactions of Atropine (Injection) in the drug label.
text: There is limited information regarding Atropine (Injection) Look-Alike Drug Names in the drug label.
text: atropine (injection)
text: Atropine (Injection) is an anticholinergic that is FDA approved for the treatment of the treatment of poisoning by susceptible organophosphorous nerve agents, pre-anesthetic medication in surgical patients, pylorospasm, antidote for mushroom poisoning due to muscarine in certain species such as Amanita muscaria.
text: There is limited information regarding Off-Label Non–Guideline-Supported Use of Atropine (Injection) in adult patients.
text: There is limited information regarding Off-Label Non–Guideline-Supported Use of Atropine (Injection) in pediatric patients.
text: There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Atropine (Injection) in women who are pregnant.
text: There is no FDA guidance on use of Atropine (Injection) during labor and delivery.
text: There is no FDA guidance on the use of Atropine (Injection) with respect to pediatric patients.
text: There is no FDA guidance on the use of Atropine (Injection) with respect to geriatric patients.
text: There is no FDA guidance on the use of Atropine (Injection) with respect to specific gender populations.
text: There is no FDA guidance on the use of Atropine (Injection) with respect to specific racial populations.
text: There is no FDA guidance on the use of Atropine (Injection) in patients with renal impairment.
text: There is no FDA guidance on the use of Atropine (Injection) in patients with hepatic impairment.
text: There is no FDA guidance on the use of Atropine (Injection) in women of reproductive potentials and males.
text: There is no FDA guidance one the use of Atropine (Injection) in patients who are immunocompromised.
text: There is limited information regarding Monitoring of Atropine (Injection) in the drug label.
text: There is limited information regarding IV Compatibility of Atropine (Injection) in the drug label.
text: There is limited information regarding Pharmacodynamics of Atropine (Injection) in the drug label.
text: There is limited information regarding Pharmacokinetics of Atropine (Injection) in the drug label.
text: There is limited information regarding Nonclinical Toxicology of Atropine (Injection) in the drug label.
text: There is limited information regarding Clinical Studies of Atropine (Injection) in the drug label.
text: There is limited information regarding Patient Counseling Information of Atropine (Injection) in the drug label.